HRP20110405T1 - Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe - Google Patents

Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe Download PDF

Info

Publication number
HRP20110405T1
HRP20110405T1 HR20110405T HRP20110405T HRP20110405T1 HR P20110405 T1 HRP20110405 T1 HR P20110405T1 HR 20110405 T HR20110405 T HR 20110405T HR P20110405 T HRP20110405 T HR P20110405T HR P20110405 T1 HRP20110405 T1 HR P20110405T1
Authority
HR
Croatia
Prior art keywords
seq
polypeptide
polypeptide according
polynucleotide
melanocortin receptor
Prior art date
Application number
HR20110405T
Other languages
English (en)
Croatian (hr)
Inventor
Cunningham Mark
Stojanovic-Susulic Vedrana
O'neil Karyn
Huang Chichi
Luo Jeffrey
Original Assignee
Centocor Ortho Biotech Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc. filed Critical Centocor Ortho Biotech Inc.
Publication of HRP20110405T1 publication Critical patent/HRP20110405T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HR20110405T 2004-10-25 2005-10-25 Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe HRP20110405T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
HRP20110405T1 true HRP20110405T1 (hr) 2011-06-30

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20110405T HRP20110405T1 (hr) 2004-10-25 2005-10-25 Mimetička tijela koja vezuju receptore melanokortina, smjese, postupci i upotrebe

Country Status (28)

Country Link
US (1) US20060105951A1 (cg-RX-API-DMAC7.html)
EP (1) EP1812046B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008517605A (cg-RX-API-DMAC7.html)
KR (1) KR101255140B1 (cg-RX-API-DMAC7.html)
CN (1) CN101437540B (cg-RX-API-DMAC7.html)
AT (1) ATE501731T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005299440B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0518411A2 (cg-RX-API-DMAC7.html)
CA (1) CA2585287A1 (cg-RX-API-DMAC7.html)
CY (1) CY1111486T1 (cg-RX-API-DMAC7.html)
DE (1) DE602005026970D1 (cg-RX-API-DMAC7.html)
DK (1) DK1812046T3 (cg-RX-API-DMAC7.html)
EA (1) EA200700944A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP077416A (cg-RX-API-DMAC7.html)
ES (1) ES2363023T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20110405T1 (cg-RX-API-DMAC7.html)
IL (1) IL182683A0 (cg-RX-API-DMAC7.html)
MA (1) MA28943B1 (cg-RX-API-DMAC7.html)
ME (1) ME01234B (cg-RX-API-DMAC7.html)
MX (1) MX2007004974A (cg-RX-API-DMAC7.html)
NO (1) NO20072499L (cg-RX-API-DMAC7.html)
PL (1) PL1812046T3 (cg-RX-API-DMAC7.html)
PT (1) PT1812046E (cg-RX-API-DMAC7.html)
RS (1) RS51789B (cg-RX-API-DMAC7.html)
SI (1) SI1812046T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN07157A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047535A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200704260B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) * 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AR072072A1 (es) * 2008-06-09 2010-08-04 Palatin Technologies Inc Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
EP2300036B1 (en) 2008-06-09 2017-04-05 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for treatment of sexual dysfunction
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
BRPI1009644B1 (pt) 2009-06-08 2022-02-08 Palatin Technologies, Inc Peptídeo cíclico ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica e uso da composição farmacêutica
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
WO2010144341A2 (en) 2009-06-08 2010-12-16 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
EP2504351A4 (en) 2009-11-23 2013-10-30 Palatin Technologies Inc MELANOCORTIN-1 RECEPTOR-SPECIFIC LINEAR PEPTIDE
AU2010321738B2 (en) 2009-11-23 2016-07-14 Palatin Technologies, Inc. Melanocortin-1 receptor-specific cyclic peptides
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー/エス 抗体重鎖のc末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01005818A (es) * 1998-12-09 2003-07-21 Eleanor Rooseveltl Inst Composicion y metodo para la regulacion del peso del cuerpo y condiciones asociadas.
WO2002006316A2 (en) * 2000-07-14 2002-01-24 Zycos, Inc. Alpha-msh related compounds and methods of use
WO2004002417A2 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) * 2002-06-28 2007-07-10 Centocor, Inc. Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
EP1750754A4 (en) * 2004-03-31 2010-09-22 Centocor Ortho Biotech Inc HUMAN GLP-1 MIMETIC BODIES, COMPOSITIONS, METHODS AND USES

Also Published As

Publication number Publication date
WO2006047535A2 (en) 2006-05-04
ATE501731T1 (de) 2011-04-15
HK1106445A1 (en) 2008-03-14
EP1812046B1 (en) 2011-03-16
PT1812046E (pt) 2011-06-28
SI1812046T1 (sl) 2011-06-30
ZA200704260B (en) 2009-03-25
CA2585287A1 (en) 2006-05-04
US20060105951A1 (en) 2006-05-18
WO2006047535A3 (en) 2008-09-04
PL1812046T3 (pl) 2011-08-31
IL182683A0 (en) 2007-09-20
RS51789B (sr) 2011-12-31
BRPI0518411A2 (pt) 2008-11-18
KR101255140B1 (ko) 2013-04-22
EA200700944A1 (ru) 2008-04-28
CY1111486T1 (el) 2015-08-05
AU2005299440B2 (en) 2011-12-15
DK1812046T3 (da) 2011-06-06
CN101437540B (zh) 2012-12-19
CN101437540A (zh) 2009-05-20
NO20072499L (no) 2007-07-16
ECSP077416A (es) 2007-05-30
JP2008517605A (ja) 2008-05-29
MA28943B1 (fr) 2007-10-01
ME01234B (me) 2013-06-20
KR20070085416A (ko) 2007-08-27
DE602005026970D1 (de) 2011-04-28
EP1812046A2 (en) 2007-08-01
MX2007004974A (es) 2007-10-17
TNSN07157A1 (en) 2008-11-21
EP1812046A4 (en) 2009-11-11
ES2363023T3 (es) 2011-07-19
AU2005299440A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
TW200745164A (en) Gene recombination antibodies composition
PE20090763A1 (es) Polipetidos, dominios variables de anticuerpos y antagonistas
DK1423419T3 (da) Hybrid- og tandemekspression af Neisseria-proteiner
CN110637036A (zh) 具有针对可溶性蛋白质的亲和性物质、切割性部分及反应性基团的化合物或其盐
IL232501A0 (en) Stable analogs of medicinal peptides and polypeptides
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
NO20043891L (no) Anti-A-beta-antistoffer og deres anvendelse
BRPI0512286A (pt) proteìnas quiméricas inibidoras da angiogênese e o uso
ATE539089T1 (de) Cyclische rezeptor-assoziierte-proteine (rap)- peptide
EA200300381A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
RU2013138469A (ru) АНТИТЕЛА К ИНТЕРЛЕЙКИНУ-1α И СПОСОБЫ ПРИМЕНЕНИЯ
ATE469176T1 (de) Modifizierter anti-tnf antikörper
EA200802059A1 (ru) Циклические конструкты натрийуретических пептидов
NZ593986A (en) Compositions comprising a protein and a carrier for topical diagnostic and therapeutic transport
PT1326851E (pt) Dipeptidos substituidos como secretagogues da hormona do crescimento
WO2015138907A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
ATE417595T1 (de) Keratin-bindende polypeptide
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
TW200508246A (en) Anti-dengue virus antibodies, compositions, methods and uses
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
DK2044125T3 (da) Sammensætninger og fremgangsmåder til indgivelse af aktiverede anti-ras-antistoffer i celler
DE60207043D1 (de) Histidine-rich glycoprotein (hrgp) zur hemmung der angiogenese
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
JP2008517605A5 (cg-RX-API-DMAC7.html)
NO930428D0 (no) Proteinstrukturen til plantetoksingelonin